Beijing Chengda Tianhe Biotechnology

Beijing Chengda Tianhe Biotechnology is a Chinese biotechnology company specializing in the research, development, and production of human vaccines. As a key subsidiary of Liaoning Chengda Biotechnology, the company focuses on high-quality biological products, most notably its rabies vaccine for human use. The company operates advanced R&D facilities in Beijing to support the group's pipeline in infectious diseases. Its portfolio includes vaccines for rabies and hemorrhagic fever with renal syndrome, utilizing Vero cell technology. Chengda Tianhe plays a critical role in the parent company's strategy to maintain its position as a leading global supplier of rabies vaccines.